Patients admitted to private super-speciality hospitals in Delhi-NCR often end up depending almost entirely on hospital-run pharmacies, laboratories, and consumable services during treatment, the Competition Commission of India (CCI) has observed in a major order linked to pricing practices at hospitals in the region. The regulator, however, closed proceedings against Delhi’s Sir Ganga Ram Hospital after saying the evidence did not conclusively prove abuse of dominant position under competition law, a TOI report stated.
The 32-page order forms part of a wider probe involving 12 leading private hospitals in Delhi NCR. The investigation examined whether admitted patients are effectively pushed to use only hospital-linked pharmacies, diagnostic centres, and medical consumables once hospitalised.
